Bitan Lab Members
Ibrar Siddique received his Ph.D. in Life Sciences from the National Institute of Immunology, India, in 2018. In his graduate work, he studied the role of small molecules in the prevention and treatment of Alzheimer’s disease in the 5X FAD mouse model. To broaden his horizons, he also investigated the role of an endoplasmic reticulum resident protein (JWA/GTRAP3-18) in the regulation of autophagy in neuronal cells. Currently, in the Bitan laboratory, he is interested in elucidating the role of molecular tweezers in the prevention of the tauopathy in an animal model system.
Helia Hosseini, B.S., graduate student
Helia is pursuing a master’s degree at UCLA. Working with neuromuscular specialists in Iran and the US, she developed a strong interest in etiology, pathogenesis and managing neurodegenerative and neuromuscular diseases, especially rare pathologies. Her interests lead her to join Bitan lab in Spring 2020. She is currently working on a project using CNS exosomes as a source of biomarkers for spinocerebellar ataxia.
Esha Chawla, undergraduate student
Esha Chawla is an undergraduate student at UCLA pursuing a Bachelor’s degree in Microbiology, Immunology, and Molecular Genetics with a minor in Biomedical Research. Having worked closely with Alzheimer’s and Parkinson’s patients, she is extremely interested in studying neurodegenerative diseases and working towards finding a cure. Her interests led her to join the Bitan Lab in the Fall of 2020, where she currently studies the effectiveness of molecular tweezers in the prevention of tauopathies in cell culture systems.
Fatemah Yacoub, undergraduate student
My name is Fatemah Yacoub and I am a third year Human Biology and Society Major. Having studied the intersection between society and medicine my entire undergraduate career, I am drawn to the intricacies of neurodegenerative disease. To me the most interesting thing about research is taking a relatively simple concept and narrowing it down to such a small mechanism and researching something that appeared so mundane. I joined Bitan Lab Fall 2020, where I currently conduct structure-activity relantionship studies of α-synuclein.